India Glycols' integrated manufacturing complex

Investor Relations

Built on disclosure and trust.

Ennature Biopharma is the natural-ingredients division of India Glycols Limited. This hub brings together our regulatory filings, financial disclosures, governance policies and shareholder information — published in one place, in the interest of transparency.

A commitment to transparency.

Good governance begins with clear, timely and complete disclosure. As Ennature Bio Pharma Limited takes shape as a distinct entity through a Scheme of Arrangement with India Glycols Limited, we are committed to keeping our shareholders, creditors and the wider investment community fully informed.

Every statutory filing, financial statement, court order and shareholder communication relating to the arrangement is made available here as it is filed with the stock exchanges and the National Company Law Tribunal. Sections not yet populated will be updated in due course as disclosures are made.

Disclosures & Filings

Explore the investor hub.

Six areas of disclosure, mirroring the requirements of SEBI (LODR) Regulations — from financial results and compliance filings to governance policies and shareholder services.

Investor Contact

Questions or grievances?

For any query relating to shares, dividends, the transfer of securities or the Scheme of Arrangement, please reach the registrar or the company directly.

Registrar & Share Transfer Agent

MCS Share Transfer Agent Limited

179-180, DSIDC Shed, 3rd Floor,
Okhla Industrial Area, Phase-1,
New Delhi — 110020

Tel: 011-41406149 / 41406150 / 41406151
admin@mcsregistrars.com

Registered Office

Ennature Biopharma

Plot No. 4, Pharma City, Selaqui,
Dehradun, Uttarakhand — 248197

Tel: +91 (5947) 269000 / 269500
Fax: +91 (5947) 275315

Head Office

Corporate & Investor Queries

2B, Sector-126, Noida,
Gautam Budh Nagar, Uttar Pradesh — 201304

Tel: +91 (120) 6860000
connect@ennaturebiopharma.com